Diploma PLC (LON:DPLM) Stock Has Consensus Price Target of GBX 7,400

by · The Markets Daily

Shares of Diploma PLC (LON:DPLM – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the eight analysts that are presently covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is GBX 7,400.

A number of research firms have recently weighed in on DPLM. Berenberg Bank reiterated a “buy” rating and issued a GBX 9,000 price target on shares of Diploma in a research report on Monday, July 20th. Royal Bank Of Canada reaffirmed an “outperform” rating and set a GBX 7,400 target price on shares of Diploma in a research note on Tuesday, September 8th. Finally, JPMorgan Chase & Co. boosted their price objective on Diploma from GBX 5,760 to GBX 8,250 and gave the company an “overweight” rating in a report on Monday, August 24th.

Read Our Latest Research Report on DPLM

Insider Activity at Diploma

In other Diploma news, insider Katie Bickerstaffe  acquired 246 shares of the business’s stock in a transaction on Wednesday, September 23rd. The shares were acquired at an average price of GBX 7,696 per share, with a total value of £18,932.16. 1.14% of the stock is currently owned by insiders.

Diploma Price Performance

LON DPLM opened at GBX 6,990 on Friday. The stock’s 50-day moving average price is GBX 7,425.45 and its two-hundred day moving average price is GBX 6,758.19. Diploma has a 1 year low of GBX 4,970 and a 1 year high of GBX 7,980. The company has a market cap of £9.37 billion, a PE ratio of 49.64, a PEG ratio of 2.82 and a beta of 0.92. The company has a current ratio of 2.06, a quick ratio of 0.80 and a debt-to-equity ratio of 47.65.

About Diploma

(Get Free Report)

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.

Featured Articles